RS54952B1 - Farmaceutski preparat koji sadrži selenit ili jedinjenja koja sadrže selenit za lečenje cervikalne displazije ili karcinoma - Google Patents
Farmaceutski preparat koji sadrži selenit ili jedinjenja koja sadrže selenit za lečenje cervikalne displazije ili karcinomaInfo
- Publication number
- RS54952B1 RS54952B1 RS20160556A RSP20160556A RS54952B1 RS 54952 B1 RS54952 B1 RS 54952B1 RS 20160556 A RS20160556 A RS 20160556A RS P20160556 A RSP20160556 A RS P20160556A RS 54952 B1 RS54952 B1 RS 54952B1
- Authority
- RS
- Serbia
- Prior art keywords
- selenite
- carcinoma
- compound
- treatment
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gynecology & Obstetrics (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ATA201/2011A AT511159A1 (de) | 2011-02-16 | 2011-02-16 | Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen |
| EP12707218.9A EP2675432B1 (de) | 2011-02-16 | 2012-02-16 | Pharmazeutische zubereitung enthaltend selenit- oder selenithaltige verbindungen zur behandlung von cervix-dysplasien oder -karzinomen |
| PCT/AT2012/000032 WO2012109685A1 (de) | 2011-02-16 | 2012-02-16 | Pharmazeutische zubereitung enthaltend selenit - oder selenithaltige verbindungen zur behandlung von cervix - dysplasien oder -karzinomen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS54952B1 true RS54952B1 (sr) | 2016-11-30 |
Family
ID=45807993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20160556A RS54952B1 (sr) | 2011-02-16 | 2012-02-16 | Farmaceutski preparat koji sadrži selenit ili jedinjenja koja sadrže selenit za lečenje cervikalne displazije ili karcinoma |
Country Status (28)
| Country | Link |
|---|---|
| US (3) | US10201566B2 (sr) |
| EP (1) | EP2675432B1 (sr) |
| JP (1) | JP5986110B2 (sr) |
| CN (2) | CN107582563B (sr) |
| AR (1) | AR085265A1 (sr) |
| AT (1) | AT511159A1 (sr) |
| AU (1) | AU2012219005B2 (sr) |
| BR (1) | BR112013020702B1 (sr) |
| CA (1) | CA2826999C (sr) |
| CL (1) | CL2013002353A1 (sr) |
| CY (1) | CY1117768T1 (sr) |
| EA (2) | EA025419B1 (sr) |
| ES (1) | ES2577150T3 (sr) |
| GE (1) | GEP201606590B (sr) |
| HK (1) | HK1243360A1 (sr) |
| HR (1) | HRP20160891T1 (sr) |
| HU (1) | HUE029811T2 (sr) |
| IL (1) | IL227981A (sr) |
| ME (1) | ME02422B (sr) |
| MX (1) | MX342098B (sr) |
| PL (1) | PL2675432T3 (sr) |
| PT (1) | PT2675432T (sr) |
| RS (1) | RS54952B1 (sr) |
| SI (1) | SI2675432T1 (sr) |
| SM (1) | SMT201600233B (sr) |
| TW (1) | TWI538678B (sr) |
| UA (1) | UA112767C2 (sr) |
| WO (1) | WO2012109685A1 (sr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102012222956A1 (de) * | 2012-12-12 | 2014-06-12 | Beiersdorf Ag | Kosmetische Zubereitungen mit Fließgrenze |
| EP3616693A1 (en) | 2018-08-28 | 2020-03-04 | Selo Medical GmbH | Therapy of high-risk human papillomavirus infections |
| WO2021041825A1 (en) * | 2019-08-30 | 2021-03-04 | Musc Foundation For Research Development | Sphingolipid-based selenium compounds, methods for their preparation, and pharmaceutical uses thereof, including as antitumor agents |
| EP3875083A1 (en) * | 2020-03-03 | 2021-09-08 | Selo Medical GmbH | Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid |
| WO2021263206A1 (en) * | 2020-06-26 | 2021-12-30 | Prothione, Llc | Compositions and methods for the treatment of covid-19 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1112164A (en) | 1977-08-02 | 1981-11-10 | Joseph R. Levitt | Therapeutic selenium compositions and the use thereof |
| US4512977A (en) | 1979-10-18 | 1985-04-23 | Lundy Research Laboratories, Inc. | Therapeutic selenium compositions and the use thereof |
| IT1161213B (it) | 1983-03-08 | 1987-03-18 | Fcn Srl | Composizioni farmaceutiche ad attivita' antineoplastica |
| US4762726A (en) | 1983-12-30 | 1988-08-09 | Kraft, Inc. | Shelf stable acid food dressings containing fibrous protein complexes |
| US4668515A (en) | 1984-03-06 | 1987-05-26 | Paul Bankit | Method and compositions for sodium selenite administration |
| US5389677B1 (en) | 1986-12-23 | 1997-07-15 | Tristrata Inc | Method of treating wrinkles using glycalic acid |
| US5153230A (en) | 1989-10-06 | 1992-10-06 | Perfective Cosmetics, Inc. | Topical skin cream composition |
| US5182104A (en) | 1991-07-16 | 1993-01-26 | Stanley Marcus | Topical virucidal composition for treatment of mucocutaneous tissue |
| CZ218394A3 (en) | 1992-03-11 | 1995-01-18 | Procter & Gamble | Plantain drinking mixtures containing granulated base |
| US5425944A (en) | 1992-10-27 | 1995-06-20 | Harich; Jakob | Antimicrobial grapefruit extract |
| US5536497A (en) | 1992-12-21 | 1996-07-16 | The Research Foundation Of State University Of New York | Fimbrial polypeptides useful in the prevention of periodontitis |
| DE4320694C2 (de) | 1993-06-22 | 1999-11-11 | Biosyn Arzneimittel Gmbh | Vewendung von Selenverbindungen zur äußeren Anwendung bei Warzen |
| US5484612A (en) | 1993-09-22 | 1996-01-16 | The Board Of Trustees Of The Leland Stanford Junior University | Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin |
| DE4335441A1 (de) | 1993-10-18 | 1995-04-20 | Hans Dipl Chem Heide | Mittel zur Gesundheitsvorsorge im Herz- Kreislaufsystem beim Menschen |
| US5512200A (en) | 1994-04-18 | 1996-04-30 | Thomas G. Bongard | Low pH Acidic Compositions |
| DE4413839C1 (de) | 1994-04-21 | 1995-10-19 | Fritz Koch Pharma Gmbh Dr Med | Kombinationspräparat |
| DE69629874T2 (de) | 1995-06-07 | 2004-07-08 | Life Science Labs, Inc., Minneapolis | Selen enthaltende Zusammensetzung zur Reduzierung der Krebshäufigkeit und zur Verlängerung des Lebensalters |
| GB2323030A (en) | 1997-03-12 | 1998-09-16 | Essential Nutrition Ltd | Dietary supplements for immunocompromised patients |
| US5999844A (en) * | 1997-04-23 | 1999-12-07 | Accumed International, Inc. | Method and apparatus for imaging and sampling diseased tissue using autofluorescence |
| US6069152A (en) | 1997-10-07 | 2000-05-30 | Eli Lilly And Company | 5-HT4 agonists and antagonists |
| GB9722361D0 (en) | 1997-10-24 | 1997-12-17 | Pharma Nord Uk Ltd | Pharmaceutical formulation for treating liver disorders |
| IT1297080B1 (it) | 1997-11-26 | 1999-08-03 | Andrea Carnevali | Composizione per il trattamento di ustioni, eritemi solari, abrasioni, piaghe e irritazioni cutanee |
| US6228347B1 (en) | 1997-12-01 | 2001-05-08 | Thione International, Inc. | Antioxidant gel for gingival conditions |
| FR2779720B1 (fr) | 1998-06-12 | 2002-08-16 | Galderma Rech Dermatologique | Nouveaux composes diarylselenures et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie |
| US6120758A (en) | 1998-07-16 | 2000-09-19 | Shaklee Corporation | Preservative system for topically applied products |
| FR2782642B1 (fr) | 1998-08-31 | 2001-12-07 | Xavier Forceville | Utilisation du selenium pour le traitement de patients atteints d'un syndrome de reponse inflammatoire systemique (sirs), et composition pour la mise en oeuvre du traitement |
| US6114348A (en) | 1999-03-10 | 2000-09-05 | Weber; Paul J. | Method of treating warts using tazarotene |
| CA2406377C (en) | 2000-05-10 | 2010-07-06 | Okopharm Forschungs-Und Entwicklungs-Gmbh | Method for reducing the surface area of silicon dioxide |
| AT412758B (de) | 2000-06-05 | 2005-07-25 | Vis Vitalis Lizenz & Handels | Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen |
| AT412448B (de) | 2001-02-13 | 2005-03-25 | Vis Vitalis Lizenz & Handels | Verwendung von selenhältigen präparaten |
| AT412703B (de) * | 2001-12-04 | 2005-06-27 | Vis Vitalis Lizenz & Handels | Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung |
-
2011
- 2011-02-16 AT ATA201/2011A patent/AT511159A1/de not_active Application Discontinuation
-
2012
- 2012-02-15 TW TW101104960A patent/TWI538678B/zh active
- 2012-02-16 UA UAA201310913A patent/UA112767C2/uk unknown
- 2012-02-16 AR ARP120100530A patent/AR085265A1/es unknown
- 2012-02-16 ME MEP-2016-123A patent/ME02422B/me unknown
- 2012-02-16 RS RS20160556A patent/RS54952B1/sr unknown
- 2012-02-16 PL PL12707218.9T patent/PL2675432T3/pl unknown
- 2012-02-16 US US14/000,133 patent/US10201566B2/en active Active
- 2012-02-16 JP JP2013553740A patent/JP5986110B2/ja active Active
- 2012-02-16 CN CN201710854416.3A patent/CN107582563B/zh active Active
- 2012-02-16 CN CN2012800083501A patent/CN103379899A/zh active Pending
- 2012-02-16 ES ES12707218.9T patent/ES2577150T3/es active Active
- 2012-02-16 GE GEAP201213231A patent/GEP201606590B/en unknown
- 2012-02-16 SI SI201230644A patent/SI2675432T1/sl unknown
- 2012-02-16 BR BR112013020702-7A patent/BR112013020702B1/pt active IP Right Grant
- 2012-02-16 HU HUE12707218A patent/HUE029811T2/hu unknown
- 2012-02-16 PT PT127072189T patent/PT2675432T/pt unknown
- 2012-02-16 MX MX2013009459A patent/MX342098B/es active IP Right Grant
- 2012-02-16 AU AU2012219005A patent/AU2012219005B2/en active Active
- 2012-02-16 CA CA2826999A patent/CA2826999C/en active Active
- 2012-02-16 EA EA201300910A patent/EA025419B1/ru unknown
- 2012-02-16 EA EA201691236A patent/EA033519B1/ru unknown
- 2012-02-16 WO PCT/AT2012/000032 patent/WO2012109685A1/de active Application Filing
- 2012-02-16 EP EP12707218.9A patent/EP2675432B1/de active Active
-
2013
- 2013-08-14 CL CL2013002353A patent/CL2013002353A1/es unknown
- 2013-08-15 IL IL227981A patent/IL227981A/en active IP Right Grant
-
2016
- 2016-07-11 CY CY20161100648T patent/CY1117768T1/el unknown
- 2016-07-15 SM SM201600233T patent/SMT201600233B/it unknown
- 2016-07-18 HR HRP20160891TT patent/HRP20160891T1/hr unknown
-
2018
- 2018-03-02 HK HK18103057.4A patent/HK1243360A1/zh unknown
- 2018-12-19 US US16/225,263 patent/US10543228B2/en active Active
-
2020
- 2020-01-09 US US16/738,797 patent/US20200206262A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1218724A1 (zh) | 用於治療瘻的組合物 | |
| HU1000069D0 (en) | New salts for the preparation of pharmaceutical composition | |
| PL2726141T3 (pl) | Urządzenie do doustnego dostarczania związków leczniczych | |
| ZA201307862B (en) | Controlled release pharmaceutical dosage forms | |
| SG11201400580VA (en) | Pharmaceutical composition for inhalation | |
| HRP20181193T1 (hr) | Farmaceutska kompozicija koja se može oralno administrirati | |
| EP2736905A4 (en) | INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF LURASIDONE AND SALTS THEREOF | |
| HK1185874A1 (zh) | 用於治療癌症的新的 -氨基- -羥基-苯甲酰胺 | |
| HK1243360A1 (zh) | 用於治療子宫頸非典型性增生或子宫頸癌的包含亞硒酸鹽或含亞硒酸鹽化合物的藥物製劑 | |
| PT2726064T (pt) | Forma de dosagem oral de libertação controlada compreendendo oxicodona | |
| EP2769718A4 (en) | MEDICINAL COMPOSITION | |
| EP2604264A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRUS DISEASES | |
| GB201118334D0 (en) | Novel dosage form | |
| PL2663318T3 (pl) | Kompozycja farmaceutyczna do leczenia raka | |
| GB201407847D0 (en) | Composition for the oral delivery of compounds | |
| IL229920A (en) | Intermediate Compounds and Method for Preparing Loracidone and its Salts | |
| HUP1100245A2 (en) | Pharmaceutical composition for the treatment of wounds | |
| HK1157189A1 (en) | Pharmaceutical composition for the treatment of tumor diseases | |
| GB201119533D0 (en) | Compounds for the treatment of neoplasia | |
| HU1000624D0 (en) | Novel salts skitable for the preparation of pharmaceutical compositions | |
| GB201104739D0 (en) | Nature's plaster/band aid |